Trial Profile
Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2016
Price :
$35
*
At a glance
- Drugs Bromfenac (Primary) ; Nepafenac (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 01 May 2016 Status changed from recruiting to completed.
- 24 Nov 2011 New trial record